Laura Martínez-Calvo

ORCID: 0000-0002-9048-7195
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Effects of Radiation Exposure
  • Dialysis and Renal Disease Management
  • Lung Cancer Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • BRCA gene mutations in cancer
  • Cancer-related molecular mechanisms research
  • Global Cancer Incidence and Screening
  • Diabetes Treatment and Management
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Complement system in diseases
  • Hormonal Regulation and Hypertension
  • Polymer Surface Interaction Studies
  • Liver Disease Diagnosis and Treatment
  • Renal Transplantation Outcomes and Treatments
  • Bone health and osteoporosis research
  • Pharmacology and Obesity Treatment
  • Advanced Sensor and Energy Harvesting Materials
  • Pleural and Pulmonary Diseases
  • Autoimmune Bullous Skin Diseases
  • Genetics and Neurodevelopmental Disorders
  • Nail Diseases and Treatments
  • Genetic Syndromes and Imprinting
  • Pathogenesis and Treatment of Hiccups
  • Cardiovascular Disease and Adiposity
  • Molecular Biology Techniques and Applications

Hospital Universitario de La Princesa
2024

Instituto de Investigación Sanitaria de Santiago
2021-2023

Fundación Pública Galega de Medicina Xenómica
2021-2023

Servicio Gallego de Salud
2022

Instituto de Medicina Genómica
2022

Universidade de Santiago de Compostela
2012-2020

Institute of Research and Innovation Parc Tauli
2019

Universitat Autònoma de Barcelona
2019

Corporació Sanitària Parc Taulí
2019

Universidad de Santiago de Chile
2015

Abstract Low‐pressure plasma‐polymerized ethylene film coatings rich in bonded oxygen groups (L‐PPE:O) were deposited on poly(ethylene terephthalate; PET) order to act as hosts for antimicrobial drugs. Increasing O 2 content the (C H 4 )/Ar–diluted (O ) gas mixture reduced deposition rate, but increased concentration of oxygen, [O], including that carboxylic acid groups, [COOH], determined by X‐ray photoelectron‐ (XPS) and Fourier transform infrared (FTIR) spectroscopies, toluidine blue...

10.1002/ppap.201100192 article EN Plasma Processes and Polymers 2012-03-06

Background There is little evidence of the effects early treatment with growth hormone (GH) in infants Prader-Willi syndrome (PWS). A prospective study was conducted to assess safety GH therapy younger than 2 years age PWS. Methods total 14 patients PWS started under and were followed over a 2-year period. deletion chromosome 15 present nine (64.3%) maternal uniparental disomy five (35.7%). The median at start 9.6 months (interquartile range [IQR] 9.0-18.3 months). Changes height standard...

10.1515/jpem-2018-0539 article EN Journal of Pediatric Endocrinology and Metabolism 2019-07-04

Several studies have identified single-nucleotide polymorphisms (SNPs) associated with adverse effects in non-small-cell lung cancer (NSCLC) patients treated radiation therapy. Here, using an independent cohort, we aimed to validate the reported associations. We selected 23 SNPs 17 genes previously radiation-induced oesophagitis for validation a cohort of 178 Spanish NSCLC patients. Of them, 18 were finally analysed, following methods described original published studies. Two replicated...

10.3390/cancers13061447 article EN Cancers 2021-03-22

<h3>Background</h3> Costs related to anaemia treatment in chronic kidney disease (CKD) patients are still under discussion. Near 80% of CKD included a peritoneal dialysis program receive erythropoietin stimulating agents for the treatment. <h3>Purpose</h3> The purpose this study is evaluate cost-effectiveness methoxy polyethylene glycol-epoetin β (C.E.R.A.) compared with darbepoetin alfa (DA) population program. <h3>Materials and methods</h3> 37 undergoing were study: 28 C.E.R.A. 9 DA. A...

10.1136/ejhpharm-2012-000074.320 article EN European Journal of Hospital Pharmacy 2012-03-12

10.1016/s1134-2072(09)70483-9 article ES FMC - Formación Médica Continuada en Atención Primaria 2009-03-01

Los eventos cardiovasculares representan la mayor complicación de diabetes. La evidencia sugiere que metformina mejora los resultados en pacientes con diabetes, especialmente el United Kingdom Prospective Diabetes Study (UKPDS) y otros estudios posteriores, por distintos mecanismos.Hay pocos seguridad cardiovascular para sulfonilureas aunque no tendrían un perfil seguro a este nivel. gliclazida parece ser mejor performance las drogas grupo. Algo similar ocurre meglitinidas, cuales datos...

10.47196/diab.v54i2sup.253 article ES cc-by-nc-nd Revista de la Sociedad Argentina de Diabetes 2020-09-22
Coming Soon ...